ライフサイエンスコーパス: pluripotent

1 arians can regenerate their entire CNS using pluripotent adult stem cells, and this process is robust

2 ) sGRP78 promotes cellular functions in both pluripotent and breast cancer cells (3) overexpression o

3 ESR cells are pluripotent and capable of differentiation into primordi

4 ation (ZGA) genes (2-cell-specific genes) in pluripotent and differentiated cells, and pre-depleting

5 trategies during stepwise conversion between pluripotent and rare totipotent two-cell embryo (2C)-lik

6 otection is solved by distinct mechanisms in pluripotent and somatic tissues.

7 tor and regulates the formation of the mouse pluripotent blastocyst.

8 entifies Srrt as a molecular guardian of the pluripotent cell state.

9 between GBA and CTSB and GBA p.N370S induced pluripotent cell-derived neurons were shown to have decr

10 switches address major safety concerns with pluripotent cell-derived therapies.

11 ine de novo synthesis pathway in cell lines, pluripotent cells and primary human T cells.

12 ning gene 9 (Sox9) is expressed initially in pluripotent cells and subsequently in ectodermal, endode

13 the major binding partner of Id proteins in pluripotent cells as the basic helix-loop-helix (bHLH) t

14 use epiblast stem cells, which correspond to pluripotent cells at a late post-implantation stage of e

15 Pluripotent cells emerge as a naive founder population i

16 CX43) gap junction communication in cultured pluripotent cells from human dental follicles (hDFC).

17 oincides with loss of epiblast pluripotency, pluripotent cells in development and in vitro can adopt

18 the insights into telomere end protection in pluripotent cells mean for the t-loop model of end prote

19 mbryos, where EPHA receptors are enriched in pluripotent cells whilst surrounding lineage-specified t

20 ficient to drive robust neural commitment in pluripotent cells, even under non-permissive conditions.

21 PRC2-bound elements function as silencers in pluripotent cells, they can transition into active tissu

22 may contribute to its biological activity in pluripotent cells.

23 to enhance reprogramming of fibroblasts into pluripotent cells.

24 germ cells given their similarities to naive pluripotent cells.

25 in establishing neural lineage commitment in pluripotent cells.

26 human embryos, and in both primed and naive pluripotent culture conditions.

27 undergoes lumenogenesis and forms the primed pluripotent egg cylinder, which is able to generate the

28 dispensable for telomere protection in mouse pluripotent embryonic stem (ES) and epiblast stem cells.

29 Pluripotent embryonic stem cells (ESCs) contain the pote

30 In the absence of Vimentin, pluripotent embryonic stem cells fail to differentiate p

31 The pluripotent epiblast gives rise to all tissues and organ

32 Following implantation, the naive pluripotent epiblast of the mouse blastocyst generates a

33 osphorylation reduces decay of m(6)A-labeled pluripotent factor transcripts and traps mouse embryonic

34 mbryo first specifies two cell lineages: the pluripotent inner cell mass that forms the fetus, and th

35 The rosette is therefore a reversible pluripotent intermediate whereby control over both pluri

36 In pluripotent mouse cells, BMP blocks entry into the neura

37 Here, we examine pluripotent, primary, differentiating, and immortalized

38 , OXPHOS), which in turn triggers reversible pluripotent quiescence specifically in the ground-state

39 c stem cells can propagate indefinitely in a pluripotent state, able to differentiate into all types

40 and traps mouse embryonic stem cells in the pluripotent state.

41 day 6.5 (E6.5) Epi when cells enter a primed pluripotent state.

42 nhibitor-regulated human naive epiblast-like pluripotent state.

43 ogenesis are linked and whether intermediate pluripotent states exist remain controversial.

44 n in gene regulatory networks that stabilize pluripotent states in vitro.

45 al event in reprogramming somatic cells into pluripotent status.

46 Treatment of human pluripotent stem (hPS) cells with F7L6 initiates transcr

47 euronal cells (iNs) from seven human-induced pluripotent stem (iPS) cell lines from subjects of Europ

48 w that intracortically grafted human induced pluripotent stem (iPS) cell-derived cortical neurons sen

49 scribe a medulloblastoma model using Induced pluripotent stem (iPS) cell-derived human neuroepithelia

50 ed-9 (Cas9)-mediated genome editing in human pluripotent stem (PS) cells mainly employ plasmids or ri

51 Coupling human induced pluripotent stem cell (hiPSC)-based technology with CRIS

52 to purify fetal astrocytes and human induced pluripotent stem cell (hiPSC)-derived astrocytes.

53 thy using DMD patient-specific human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and

54 odeling cardiac disorders with human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes is

55 cell cultures generated from multiple human pluripotent stem cell (hPSC) myogenic differentiation pr

56 Here, we present a multiplex human pluripotent stem cell (hPSC) platform, in which 30 isoge

57 Here, we develop a human pluripotent stem cell (hPSC)-based microglial chimeric m

58 We report a 96-well-based array of 3D human pluripotent stem cell (hPSC)-derived cardiac microtissue

59 pidly-expanding therapeutic potential, human pluripotent stem cell (hPSC)-derived cell therapies cont

60 Human pluripotent stem cell (hPSC)-derived intestinal organoid

61 RNA-seq based analysis of 310 induced pluripotent stem cell (iPSC) clones derived from 100 ind

62 s, are differentially spliced during induced pluripotent stem cell (iPSC) differentiation and in tumo

63 In response to this need, an induced pluripotent stem cell (iPSC) disease model has been used

64 ene networks dysregulated in a human induced pluripotent stem cell (iPSC) disease model of a common f

65 emonstrate complete correction of an induced pluripotent stem cell (iPSC) line derived from a C9orf72

66 Using five control induced pluripotent stem cell (iPSC) lines and seven iPSC lines

67 Cultures of isogenic induced pluripotent stem cell (iPSC) lines with and without PARK

68 Recently, human- induced pluripotent stem cell (iPSC) models revealed an importan

69 ar envelope invaginations in patient induced pluripotent stem cell (iPSC) neurons and postmortem tiss

70 e, we report the generation of human induced pluripotent stem cell (iPSC) reporter lines in which flu

71 seases and conditions in which human induced pluripotent stem cell (iPSC)-based regenerative medicine

72 n this study, we established a human induced pluripotent stem cell (iPSC)-derived air-liquid interfac

73 To this end, we deployed human-induced pluripotent stem cell (iPSC)-derived BMEC-like cells as

74 0 nM - 100 muM) for effects in human induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CMs

75 Mature induced pluripotent stem cell (iPSC)-derived cortical neurons se

76 Notably, in static human induced pluripotent stem cell (iPSC)-derived HE culture, compoun

77 Armed with patient-derived cell lines and pluripotent stem cell (iPSC)-derived kidney organoids, i

78 therefore used highly enriched human induced pluripotent stem cell (iPSC)-derived motor neurons and a

79 creased 5-HT concentrations in human induced pluripotent stem cell (iPSC)-derived neuron culture medi

80 ast lines and generated six lines of induced pluripotent stem cell (iPSC)-derived neurons covering a

81 Using human induced pluripotent stem cell (iPSC)-derived neurons that model

82 genome sequencing (WGS) with patient-induced pluripotent stem cell (iPSC)-derived retinal organoids (

83 sociated genetic mutation in patient induced pluripotent stem cell (iPSC)-derived SNOs.

84 ere, we report the generation of two induced pluripotent stem cell (iPSC)-lines from patients with ra

85 d TNF-alpha using an in vitro murine induced pluripotent stem cell (miPSC) model system.

86 Our knowledge of pluripotent stem cell (PSC) biology has advanced to the

87 Dynamic pluripotent stem cell (PSC) states are in vitro adaptati

88 plore mesoderm lineage-bias within the human pluripotent stem cell compartment.

89 The immature phenotype of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs)

90 re we evaluate if transplantation of induced pluripotent stem cell derived TM like cells (iPSC-TM) re

91 type specification, with broad relevance for pluripotent stem cell differentiation and disease modeli

92 e of 'cross-antagonistic' signalling to trap pluripotent stem cell intermediates with different linea

93 mutations engineered in subclones of a human pluripotent stem cell line can be investigated in parall

94 Under these conditions, we derive several pluripotent stem cell lines that express pluripotency-as

95 The introduction of induced pluripotent stem cell methodology enabled better modelin

96 on 3 of FMR1, we generated an isogenic human pluripotent stem cell model of FXS that shows complete l

97 harboring these mutations, a patient-induced pluripotent stem cell model was used.

98 We created a toolkit of human induced pluripotent stem cell models and functional assays using

99 utilize pluripotent stem cell models to demonstrate that a prima

100 at can be interrogated with species-matching pluripotent stem cell models.

101 t that reprogramming to a stable naive human pluripotent stem cell state may effectively erase dysfun

102 riventricular endothelial cells, using human pluripotent stem cell technology, and extensively charac

103 cularly powerful in combination with induced pluripotent stem cell technology, which enables the deri

104 e of high-throughput assays in human induced pluripotent stem cell-based neurodevelopmental models to

105 Here we developed an induced pluripotent stem cell-based three-dimensional model that

106 ntitative phosphoproteomic survey of induced pluripotent stem cell-derived AT2s (iAT2s) infected with

107 epithelium with SARS-CoV-2 by using induced pluripotent stem cell-derived AT2s that have been adapte

108 ding EndoC-beta cell lines and human induced pluripotent stem cell-derived beta-like cells.

109 reduced FcRn engagement across human induced pluripotent stem cell-derived brain endothelial-like cel

110 characterization conducted in human induced pluripotent stem cell-derived cardiac myocytes (hiPSC-CM

111 impacted by recent advances in human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) t

112 his process and lead to better maturation of pluripotent stem cell-derived cardiomyocyte and novel th

113 on recently due to the maturation defects in pluripotent stem cell-derived cardiomyocyte, its antagon

114 c kidney (HEK293) cells and in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

115 these signaling modulators to human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

116 Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

117 ventricular cardiomyocytes and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

118 s for creating cardioprotective drugs, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs)

119 signals on human cardiomyocytes, using human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs)

120 The development of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs)

121 We previously reported that induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs)

122 A primary limitation in the use of pluripotent stem cell-derived cardiomyocytes (PSC-CMs) f

123 Pluripotent stem cell-derived cardiomyocytes (PSC-CMs) h

124 Accumulating evidence suggests that human pluripotent stem cell-derived cardiomyocytes can affect

125 iac pathogenesis in patient-specific induced pluripotent stem cell-derived cardiomyocytes from NS pat

126 PHTF1 was upregulated in human-induced pluripotent stem cell-derived cardiomyocytes from patien

127 Using human induced pluripotent stem cell-derived cardiomyocytes in cardiac

128 Patients' induced pluripotent stem cell-derived cardiomyocytes recapitulat

129 urrent (I (NaP)) recorded from human induced pluripotent stem cell-derived cardiomyocytes.

130 HL1 murine cardiomyocytes and human induced pluripotent stem cell-derived cardiomyocytes.

131 red heart tissue from knockout human induced pluripotent stem cell-derived cardiomyocytes.

132 Induced pluripotent stem cell-derived dopaminergic cultures reve

133 s cultured primary human hepatocytes (PHHs), pluripotent stem cell-derived hepatocyte-like cells (HLC

134 , they received either endobronchial induced pluripotent stem cell-derived human MSCs (hMSCs) (n = 7)

135 lomerular function in the transplanted human pluripotent stem cell-derived kidney tissue 1, 2, and 3

136 systems from primary mouse and human induced pluripotent stem cell-derived lung epithelial cells to m

137 we used genetically engineered human induced pluripotent stem cell-derived microglia-like cells to sh

138 ovo in schizophrenia, and studies of induced pluripotent stem cell-derived neural progenitor cells.

139 both the prefrontal cortex (PFC) and induced pluripotent stem cell-derived neuronal cultures from pat

140 Truncated STMN2 accumulated in human induced pluripotent stem cell-derived neurons depleted of TDP-43

141 On human induced pluripotent stem cell-derived neurons, the nanobody prev

142 KPNA7-interacting proteins in human induced pluripotent stem cell-derived neurons.

143 ptake in H4 neuroglioma cells and in induced pluripotent stem cell-derived neurons.

144 ockout (CISH(-/-)) NK cells using an induced pluripotent stem cell-derived NK cell (iPSC-NK cell) pla

145 n, we optimized a protocol to generate human pluripotent stem cell-derived Purkinje cells (hPSC-PCs)

146 Here, we utilized induced pluripotent stem cell-derived retinal pigment epithelium

147 cessible Chromatin using sequencing on human pluripotent stem cell-derived SAN-like pacemaker cells a

148 We found that human induced pluripotent stem cell-derived sensory neurons expressed

149 ioink to 3-dimensionally print human induced pluripotent stem cell-laden structures with 2 chambers a

150 tem cells (WA-01, passage 27-40) and induced pluripotent stem cells (GM23338) with a series of chemic

151 of EpCAM(+) cells derived from human induced pluripotent stem cells (hiPSC) at the physiological air-

152 nd disease-primed conventional human induced pluripotent stem cells (hiPSC) can be significantly impr

153 ) retinal organoids (ROs) from human induced pluripotent stem cells (hiPSCs) derived from an LCA4 pat

154 Towards this, patient-derived human induced pluripotent stem cells (hiPSCs) have demonstrated consid

155 Human induced pluripotent stem cells (hiPSCs) have revolutionized rese

156 We differentiated human induced pluripotent stem cells (hiPSCs) into NPCs to generate tw

157 be a protocol to differentiate human induced pluripotent stem cells (hiPSCs) into oogonia in vitro.

158 itor cells (NPCs) derived from human induced pluripotent stem cells (hiPSCs) of ASD individuals with

159 blastocysts were injected with human induced pluripotent stem cells (hiPSCs) or hiPSCs overexpressing

160 Human induced pluripotent stem cells (hiPSCs) provide a potentially un

161 Human induced pluripotent stem cells (hiPSCs) provide a powerful platf

162 paradigm using genetically engineered human pluripotent stem cells (hiPSCs) that captures authentic

163 ation of SALL4 was examined in human induced pluripotent stem cells (hiPSCs) that were differentiated

164 re of brain tissue.We employed human induced pluripotent stem cells (hiPSCs) to compare patterns of A

165 IMPORTANCE This study employed human induced pluripotent stem cells (hiPSCs) to model the interaction

166 these phenotypes, 65 clones of human induced pluripotent stem cells (hiPSCs) were generated from 13 i

167 splice regulatory elements in human induced pluripotent stem cells (hiPSCs), and develop a software

168 nt gene expression profiles in human induced pluripotent stem cells (hiPSCs), indicating isoform-spec

169 rived from clinically relevant human induced pluripotent stem cells (hiPSCs).

170 Archetypal human pluripotent stem cells (hPSC) are widely considered to b

171 Naive human pluripotent stem cells (hPSC) resemble the embryonic epi

172 developed a lung organoid model using human pluripotent stem cells (hPSC-LOs).

173 ranscriptomics between differentiating human pluripotent stem cells (hPSCs) and developing mouse neur

174 In this report, human pluripotent stem cells (hPSCs) are subject to directed d

175 We investigate how human pluripotent stem cells (hPSCs) differentiate into pancre

176 Human pluripotent stem cells (hPSCs) offer an unprecedented op

177 Naive human pluripotent stem cells (hPSCs) provide a unique experime

178 The in vitro differentiation of human pluripotent stem cells (hPSCs) recapitulates some of the

179 Parallel studies using human pluripotent stem cells (hPSCs) revealed that HOXA(neg/lo

180 stablished method to generate ECs from human pluripotent stem cells (hPSCs), and then we overexpresse

181 a CLDN5-P2A-GFP stable cell line from human pluripotent stem cells (hPSCs), directed their different

182 in cardiomyocyte differentiation from human pluripotent stem cells (hPSCs).

183 of cell and organoid derivatives from human pluripotent stem cells (hPSCs).

184 ene studies and genome-wide screens in human pluripotent stem cells (hPSCs).

185 In this study, induced pluripotent stem cells (iPSC)-derived neuronal stem cell

186 ells and cardiomyocytes derived from induced pluripotent stem cells (iPSCs) and used a monomeric Fc-l

187 to produce cardiomyocytes from human induced pluripotent stem cells (iPSCs) are capable of generating

188 NA sequencing in both mice and human induced pluripotent stem cells (iPSCs) derived from bipolar pati

189 chizophrenia (SCZ) when matured-from induced pluripotent stem cells (iPSCs) derived from healthy cont

190 al muscle models were developed from induced pluripotent stem cells (iPSCs) derived from healthy indi

191 ng a time course experiment of human induced pluripotent stem cells (iPSCs) differentiating into card

192 differential response, we generated induced pluripotent stem cells (iPSCs) from full responders and

193 IMPA1 deficiency in ID, we generated induced pluripotent stem cells (iPSCs) from patients and neuroty

194 rogramming of human somatic cells to induced pluripotent stem cells (iPSCs) generates valuable resour

195 derived from embryonic stem cells or induced pluripotent stem cells (iPSCs) has been considered.

196 Induced pluripotent stem cells (iPSCs) have the potential to ove

197 Brain organoids derived from induced pluripotent stem cells (iPSCs) of the patients are a pow

198 Cardiomyocytes derived from human induced pluripotent stem cells (iPSCs) provide a unique opportun

199 The advent of human induced pluripotent stem cells (iPSCs) provided a means for avoi

200 Induced pluripotent stem cells (iPSCs) were generated from an in

201 velop cerebral organoid models using induced pluripotent stem cells (iPSCs) with APOE epsilon3/epsilo

202 issue-specific stem cells from human induced pluripotent stem cells (iPSCs) would have broad reaching

203 p formed by HGPS-SMCs generated from induced pluripotent stem cells (iPSCs), to study their vulnerabi

204 Using proband-derived induced pluripotent stem cells (iPSCs), we have successfully mod

205 se 2 (LRRK2) gene identified patient induced pluripotent stem cells (iPSCs), which were used to isola

206 es AD-related lysosomal defects in inducible pluripotent stem cells (iPSCs)-derived brain cells of Ap

207 her can convert human fibroblasts to induced pluripotent stem cells (iPSCs).

208 SNORD116 in neurons derived from PWS induced pluripotent stem cells (iPSCs).

209 and gene expression levels in human induced pluripotent stem cells (iPSCs).

210 iomyocyte differentiation from human induced pluripotent stem cells (iPSCs).

211 a PRC2.1 or 2.2 subcomplex in human induced pluripotent stem cells (iPSCs).

212 generated from PITRM1-knockout human induced pluripotent stem cells (iPSCs).

213 d a model of CSCs by culturing mouse induced pluripotent stem cells (miPSCs) for four weeks in the pr

214 r epidermal vulnerabilities, patient-derived pluripotent stem cells (PSCs) conditional for the FA pat

215 Here, we engineer AEC2s from human pluripotent stem cells (PSCs) in vitro and use time-seri

216 binding for chromatin localization in human pluripotent stem cells and in turn for defining cellular

217 In both induced pluripotent stem cells and induced neurons, gene copy nu

218 dification that specifies the basic state of pluripotent stem cells and regulates the developmental t

219 e the conversion of somatic cells to induced pluripotent stem cells and rejuvenation of the germline

220 how single-cell technologies, human-induced pluripotent stem cells and systems pharmacogenomics acce

221 single DNA molecules in the genome of mouse pluripotent stem cells and using CRISPR/Cas9-mediated en

222 like cells differentiated from human induced pluripotent stem cells are further induced into M-prospe

223 e brain organoids and assembloids from human pluripotent stem cells are increasingly utilized to mode

224 Overall the results suggest that pluripotent stem cells are not subject to unusually high

225 emergence of brain organoids generated from pluripotent stem cells as a model to compensate for the

226 Using isogenic human pluripotent stem cells as a model to investigate the pat

227 DNMT3A was knocked out in human induced pluripotent stem cells by CRISPR/Cas9gene editing.

228 on of developmental transcription factors in pluripotent stem cells by methylating lysine 27 on histo

229 re, we tackle this question in human induced pluripotent stem cells by using multiple complementary a

230 ement based on generating neurons from human pluripotent stem cells could effectively treat in the fu

231 Mutant TNNT2:p.R286H iPSC-CMs (induced pluripotent stem cells derived cardiomyocytes) show hype

232 In this study, both induced pluripotent stem cells derived from a MFS-patient and th

233 ic lineage cells differentiated from induced pluripotent stem cells derived from an affected individu

234 Pluripotent stem cells differentiate with varying effici

235 lex and coordinated pathway originating from pluripotent stem cells during embryogenesis and continui

236 hus, we identify chromosome-bound factors in pluripotent stem cells during mitosis and reveal that PR

237 human cardiac myocytes derived from induced pluripotent stem cells during oxidative stress.

238 ates the usefulness of using patient-induced pluripotent stem cells for targeted discovery and valida

239 Here we generated induced pluripotent stem cells from 15 individuals with 22q11DS

240 ultures containing dopamine neurons, induced pluripotent stem cells from patients with YOPD showed in

241 Conversion of human pluripotent stem cells from primed to naive state is acc

242 patient-specific model, we generated induced pluripotent stem cells from three patients with missense

243 as their recapitulation in vitro from human pluripotent stem cells has the potential to generate aut

244 and mechanical stimulation of human induced pluripotent stem cells in 6-well plates.

245 subtelomeres, and at higher levels in mouse pluripotent stem cells in comparison with mouse embryoni

246 It is well established that pluripotent stem cells in fetal and postnatal liver (LPC

247 Plants maintain populations of pluripotent stem cells in shoot apical meristems (SAMs),

248 man development, we examine the potential of pluripotent stem cells in the context of bioprinting tow

249 ith improved protocols differentiating human pluripotent stem cells into beta-like cells has opened u

250 otocols have been published to differentiate pluripotent stem cells into RPE cells suitable for disea

251 astrocytes differentiated from human-induced pluripotent stem cells into the mouse cortex.

252 of oncogenic polymorphisms arising in naive pluripotent stem cells is close to zero.

253 that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical

254 Dopaminergic neurons derived from induced pluripotent stem cells of PD patients carrying LRRK2 G20

255 After human induced pluripotent stem cells proliferated to a sufficient dens

256 man somatic cells to primed or naive induced pluripotent stem cells recapitulates the stages of early

257 CRISPR-edited human induced pluripotent stem cells recapitulating the variant were d

258 A sequencing (RNA-seq) data from human naive pluripotent stem cells reported multiple point "mutation

259 model nuclear shape changes of human-induced pluripotent stem cells resulting from drug treatments.

260 Brain organoids grown from human pluripotent stem cells self-organize into cytoarchitectu

261 de in producing mature beta-cells from human pluripotent stem cells that respond appropriately to dyn

262 reated by the use of patient-derived induced pluripotent stem cells to generate both the motor neuron

263 also used cardiomyocytes derived from human pluripotent stem cells to model the contribution of TRPM

264 ortical spheroids derived from human induced pluripotent stem cells to replicate this neurodevelopmen

265 e cells differentiated in vitro from induced pluripotent stem cells to show that these cells exhibit

266 Moreover, induced pluripotent stem cells used to model ND diseases are dis

267 human pancreatic alpha (SC-alpha) cells from pluripotent stem cells via a transient pre-alpha cell in

268 poietic potential of patient-derived induced pluripotent stem cells was skewed toward the myeloid lin

269 on human cardiomyocytes derived from induced pluripotent stem cells was then studied.

270 Here induced pluripotent stem cells were generated from control indiv

271 onic stem cells, and patient-derived induced pluripotent stem cells) to investigate the mechanism thr

272 n pneumocyte-like cells derived from induced pluripotent stem cells, and apilimod also demonstrated a

273 cortical neurons differentiated from induced pluripotent stem cells, as well as post-mortem tissue fr

274 redible advances in cell biology, namely, in pluripotent stem cells, have also contributed to the lat

275 tem and progenitor cells, stromal cells, and pluripotent stem cells, have been investigated over the

276 recursors, including patient-derived induced pluripotent stem cells, we further demonstrated that MCM

277 Here, using patient-derived induced pluripotent stem cells, we show that a mutation at the C

278 tive strategy is to print with human induced pluripotent stem cells, which can proliferate to high de

279 comprise dopamine neurons derived from human pluripotent stem cells, which have several advantages ov

280 ial for the long-term proliferation of human pluripotent stem cells, while their telomere length set

281 the nucleus utilizing isogenic human-induced pluripotent stem cells-derived neurons from PD patients

282 te differentiation of isogenic human induced pluripotent stem cells.

283 e feature of mammalian development and naive pluripotent stem cells.

284 o generate pancreatic progenitors from human pluripotent stem cells.

285 human cardiac myocytes derived from induced pluripotent stem cells.

286 domain, into marmoset embryonic and induced pluripotent stem cells.

287 inhibitory neurons differentiated from human pluripotent stem cells.

288 nd cardiomyocytes derived from human induced pluripotent stem cells.

289 tructural features of the liver, using human pluripotent stem cells.

290 increased CAG repeat expansion in HD-induced pluripotent stem cells.

291 on the majority of RNA:DNA hybrids in human pluripotent stem cells.

292 th early cardiac and neural development from pluripotent stem cells.

293 human cardiac myocytes derived from induced pluripotent stem cells.

294 rating similar lung epithelial lineages from pluripotent stem cells.

295 ifferentiation protocol for generating human pluripotent stem-cell-derived beta (SC-beta) cells with

296 Here, we use primate pluripotent stem-cell-derived cardiomyocytes that mimic

297 ered in nuclei isolated from C9orf72 induced pluripotent stem-cell-derived neurons (iPSNs).

298 ing a model of chronic HIF1a accumulation in pluripotent-stem-cell-derived oligodendrocyte progenitor

299 Dmd C3333Y animals, induced-pluripotent-stem-cell-derived skeletal muscle cells from

300 eive the necessary regulatory cues to remain pluripotent until the appropriate time when they are sti